Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aisanberry Biotechnology is a life sciences company specializing in the research, development, and commercialization of bioactive compounds derived from berries, particularly focusing on anthocyanins and other polyphenols. The company leverages advanced extraction and purification technologies to produce high-potency botanical extracts intended for use in functional foods, dietary supplements, and pharmaceutical applications. Their primary focus is on addressing metabolic health, oxidative stress, and chronic inflammation through natural, evidence-based interventions. Aisanberry operates with a vertically integrated model, overseeing the process from raw material sourcing to final product formulation. The company's portfolio includes standardized extracts that are marketed globally to health and wellness manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aisanberry Biotechnology.